Breaking News
PVH   MongoDB   Five Below   Lululemon   Lands’ End   Ciena   DocuSign   Broadcom   Dollar Tree  
  • ALL
    • Breaking News
    Oct 11, 2023
    • Humana Inc declined 1.2% to $494.0 after the health insurance company said chief executive Bruce Broussard will step down in the second-half of 2024. 

      The company named health care industry veteran Jim Rechtin as President and Chief Operating Officer effective January 8, 2024, as part of a long-planned CEO transition and Rechtin will assume chief executive's role after Broussard steps down.  
      • Novo Nordisk AS jumped 3.4% to  $96.34 after the Danish company said it will stop kidney trials earlier because of promising results.

        The company's drug therapy Ozempic uses active ingredient semaglutide, which the company also uses in the making of its weight-loss drug Wegovy. 

        After the Novo Nordisk's news,  Davita Inc plunged 18% to $54.58 and Fresenius Medical Care dropped 16.7% to $17.45. 
        • Pioneer Natural Resources Company jumped 1.9% to $241.79 after the company agreed to be acquired by Exxon Mobil in an all-stock merger for $253 a share or $60 billion. 
          • The producer price index rose 0.5% in September from the previous month, and slower than 0.7% in August, the U.S. Bureau of Labor Statistics reported Wednesday. 

            However, wholesale inflation on an annual basis accelerated to 2.2% in the month from 2.0% in the previous month and advanced for the third month in a row. 
            • Oct 10, 2023
            • PepsiCo gained 1.5% to $163.81 after the beverage and food company reported its quarterly results and the company also lifted its full-year outlook. 

              Net revenue in the third quarter ending in September increased 6.7% to $23.45 billion from $21.97 billion and net income attributable to shareholders increased to $3.09 billion from $2.70 billion and diluted earnings per share advanced to $2.24 from $1.95 a year ago. 

              In North America, beverage sales increased 8%, Frito Lay sales rose 7% and Quaker Foods advanced 5%. 

              The company slightly revised higher its 2023 earnings outlook and estimated core earnings per share of $7.54 compared to its previous estimate of $7.47 and compared to $6.79 a year ago.   
              • Bristol-Myers Squibb Co edged up 0.1% to $56.68 after the company agreed to acquire San Diego-based Mirati Therapeutics for $58 a share or $4.8 billion on Sunday evening. 

                The company also agreed to as much as additional $1 billion  in milestone payments. 

                With the purchase of Mirati, Bristol-Myers expanded its cancer treatment portfolio after Mirati's non-small cell lung cancer drug Krazati was approved by the U.S. FDA.  
                • Palantir Technologies Inc increased 2.7% to $18.09 on news that the U.S. Army assigned a $250 million contract to test and develop artificial Intelligence tools.
                  • Oct 6, 2023
                  • Aehr Test Systems plunged 16.1% to $37.06 despite the company reporting quarterly earnings and revenue ahead of expectations set by analysts. 

                    The semiconductor testing equipment maker said net revenue in the fiscal first quarter ending in August jumped 93% to $20.6 million and net income advanced to $4.7 million from $.0.59 million and diluted earnings per share rose to 16 cents from 2 cents a year ago. 

                    The company reiterated its revenue in the fiscal year 2024 ending in May 2024 of  $100 million and net income of $28 million.   
                    • Tesla Inc fell 2.5% to $255.14 after the electric vehicle maker lowered prices on its Model 3 and Model Y vehicles in the U.S. 

                      The move follows the recent weakness in U.S. sales after the company reported weaker-than-expected sales in the third quarter. 
                      • Levi Strauss & Company decreased 1% to $13.08 after the apparel maker reported third-quarter revenue below market's expectations and the company also lowered its full-year revenue outlook. 

                        Net revenue in the quarter was nearly unchanged at $1.5 billion and net income plunged 94% to $10 million from $173 million and diluted earnings per share dropped to 2 cents  from 43 cents a year ago. 

                        The company took an impairment charge of $90.2 million related to $400million Beyond Yoga acquisition in late 2021.

                        The recognition of the Beyond Yoga impairment charges negatively impacted after-tax diluted earnings per share by 17 cents.  

                        The company returned $48 million to shareholder through a dividend of 12 cents a share and apparel maker did not purchase any shares in the quarter. 

                        Levi announced a 12 cents per share dividend to shareholders on record on October 26 and payable on November 9.  

                        The company forecasted 2023 revenue between flat and 1% increase from the previous year and said customers are searching for bargains and buying fewer items because of inflation and higher mortgages and gasoline prices at pump stations.